in a large number of transactions
across a wide spectrum of industries
FORT LAUDERDALE, Fla. (May 6, 2021) – Farlie Turner & Co., LLC (“Farlie Turner”), a leading investment bank serving middle market companies, is pleased to announce that it advised TMJ Solutions, Inc. dba TMJ Concepts (“TMJ” or the “Company”) in a sale transaction to Stryker Corporation. Terms of the transaction were not disclosed.
TMJ is the industry leader in the design, manufacturing and marketing of a patient-fitted temporomandibular joint prosthesis system and components used in oral-maxillofacial and oncological procedures worldwide. The Company sells its products to medical centers located throughout the United States and in select international countries and distributes its devices and components to 20 additional countries through a diverse distribution network. The Company is widely recognized as the forerunner in the total joint reconstruction market, having been the first company to obtain premarket approval from the U.S. Food and Drug Administration for its patient-fitted prosthesis in 1999.
“We valued Farlie Turner’s deal expertise and advice during the transaction. Their team provided outstanding execution, which enabled the shareholders and our management team to achieve our collective objectives. We achieved an excellent result and are excited to see the Company capitalize on its strong market position under its new ownership with Stryker,” said Bill Wachter, former Chairman of TMJ.
Commenting on the transaction, Mike Turner, Managing Director of Farlie Turner, remarked: “We greatly enjoyed working with the TMJ shareholders and management. They built an incredible company that provided patients suffering from TMJ issues with a life-changing solution and, along the way, built an excellent brand and reputation in the market. Our representation of TMJ adds another company to our list of closed healthcare transactions this year and is an example of the broad expertise our team has in the sector.”
Besides Mr. Turner, the Farlie Turner transaction team included Craig Farlie and Chris Henry.